Spots Global Cancer Trial Database for Phase 2 Study of VELCADE With Fludarabine in Comparison to Rituximab With Fludarabine in Follicular Lymphoma Patients Previously Treated With Rituximab
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Phase 2 Study of VELCADE With Fludarabine in Comparison to Rituximab With Fludarabine in Follicular Lymphoma Patients Previously Treated With Rituximab
Official Title: A Randomized, Open-Label, Multicenter Phase 2 Study of VELCADE With Fludarabine in Comparison to Rituximab With Fludarabine in Follicular Lymphoma Patients Previously Treated With Rituximab
Study ID: NCT00850499
Conditions
Study Description
Brief Summary: This is a randomized, open-label, active-control, multicenter Phase 2 study of VELCADE+fludarabine in comparison with rituximab+fludarabine in subjects with relapsed advanced follicular lymphoma. Eligible subjects will be randomized in a 1:1 ratio between the 2 treatment arms (55 subjects per arm).
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
CHU d'Amiens, Amiens, 80, , France
Institut Bergonie, Bordeaux, 33, , France
CHU Hotel Dieu, Clermont Ferrand, 63, , France
Centre Victor Hugo, Le Mans, 72, , France
CHU Caremeau, Nimes, 30, , France
Hoptial Saint Louis, Paris Cedex 10, 75, , France
Hopital Cochin, Paris, 75, Cedex 14, , France
Klinikum Bamberg, fachbereich 3, Bamberg, , Germany
Vivantes Klinikum am Urban, Berlin, BE, , Germany
Charite, group Benjamin Franklin, Berlin, , Germany
Hospital Spandau, Berlin, , Germany
Universitaetsklinikum Frankfurt, Frankfurt, , Germany
Universitatsklinikum Gottingen, zentrum Innere medicin, Gottingen, , Germany
Evangelisches Krankenhaus Hamm, Hamm, , Germany
Klinikum Idar-Oberstein GmbH, Idar-Oberstein, , Germany
Universitaetsklinikum Jena, Jena, , Germany
Universitaetsklinikum Leipzig, Leipzig, , Germany
Universitaetsklinikum Mainz, Mainz, , Germany
Robert Bosch Krankenhaus, Stuttgart, , Germany
Mutterhaus der Borromaeerinnen, Trier, , Germany
Universitatsklinikum Ulm, Ulm, , Germany
Klinikum der Stadt Villinger-Schwenningen, Villingen-Schwenningen, , Germany
Laiko Hospital - 1st Dept. of Propaedeutic Internal Medicine, Athens, , Greece
University Hospital of Heraklion- Department of Hematology, Heraklion- Crete, , Greece
Haemek Medical Center - Hematology Department, Afula, , Israel
Rambam Med.Center - Hematology Institute, Haifa, , Israel
Hadassah University Hospital - Hematology Department, Jerusalem, , Israel
Rabin Medical Center - Hematology Institute, Petach Tikva, , Israel
Sheba MC - Hematology Institute, Ramat Gan, , Israel
Policlinico di Bari, Bari, , Italy
Istituto Di Ematologia E Oncologia Medica - L.A. Seragnoli - Policlinico S.Orsola Malpighi, Bologna, , Italy
Clinica di Ematologia DIMI - A.O. Ospedale S. Martino, Genova, , Italy
Ospedale Niguarda Ca' Granda, Milano, , Italy
Azienda Ospedaliera Antonio Cardarelli, Napoli, , Italy
Ospedale Policlinico San Matteo Irccs, Pavia, , Italy
A.O.Univ.Pisana-Osp. Santa Chiara, Pisa, , Italy
Università La Sapienza, Dipartimento di Biotecnologie Cellulari ed Ematologia, Via Benevento, 6, Roma, , Italy
Azienda Ospedaliera Santa Maria di Terni, Terni, , Italy
Divisione di Ematologia Ospedale San Bortolo - Hematology, Vicenza, , Italy
Hospital Puerta del Mar, Secretaría de Hematología, 1ª planta, Cadiz N/a, , Spain
Hospital General Universitario Morales Meseguer, Secretaría de Hematología, 1ª planta, Murcia N/a, , Spain
Hospital Clinico Universitario Salamanca, Servicio de Hematología, 4º Planta, Salamanca, , Spain
Kantonsspital St.Gallen Department of Oncology/Hematology, St. Gallen, , Switzerland
Contact Details
Name: Medical Monitor
Affiliation: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
